Solid profitability despite headwinds in the quarter Third quarter 2024Order intake for the third quarter amounted to 99.6 (166.8) MSEK, a decrease of 40 percent. At fixed exchange rates, the decrease ...

Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products ...

In his first appearance before France’s fractured lower house of Parliament, Prime Minister Michel Barnier pleaded on Tuesday with lawmakers to work with his government on tackling the country ...

Elekta AB engages in the business of human care, which specializes in the treatment of cancers and brain disorders. It provides oncologists, radiation therapists, neurosurgeons, and other medical ...

0:38 Canadians arrive at Montreal airport from Lebanon Prime Minister Justin Trudeau is headed to France on Thursday to attend the Francophonie summit, where the shadow of a wider conflict in the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Global Internal Radiation Therapy Market was valued at approximately USD 1.12 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 6.23% from 2024 to 2032. Read the ...

The Global Robotic Radiotherapy Market, valued at approximately USD 1.1 billion in 2023, is anticipated to witness a robust growth trajectory with a compound annual growth rate (CAGR) of 11.9% over ...

AMS has signed a Joint Venture (“JV”) agreement with Hospit Extended 10-year Agreement to Upgrade Gamma Knife® Perfexion™ with Elekta EspritSAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE ...